TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%

Bulletin Express

06/18

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.

Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.

The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1103580602"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103580602\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103580602?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-18 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103580602","market":"hk","top_or_hot":-1,"title":"TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.</p>\n<p>Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.</p>\n<p>The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED Repurchases 0.54 Million A-Shares, Trimming Free Float by 0.08%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-06-18 17:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.</p>\n<p>Following the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.</p>\n<p>The shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格醫藥","start_time":0,"source_url":"","article_id":"1103580602","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103580602","pubTimestamp":1781773554,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药回购54万股A股，自由流通量削减0.08%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) disclosed a share repurchase executed on 18 June 2026 via the Shenzhen Stock Exchange, acquiring 542,400 A-shares at prices ranging from RMB 39.33 to RMB 39.98 per share. The volume-weighted average repurchase price was RMB 39.85, bringing total cash outflow to approximately RMB 21.62 million.\nFollowing the transaction, TIGERMED’s outstanding A-shares (excluding treasury shares) decreased by 0.08% from 713.40 million to 712.86 million. Concurrently, treasury shares rose from 24.50 million to 25.04 million, while the company’s total issued share count remained unchanged at 737.90 million.\nThe shares were retained as treasury stock; no cancellations were reported as of the 18 June 2026 closing balance date. The company confirmed that the repurchase complied with Shenzhen Stock Exchange regulations and related Hong Kong Stock Exchange rules governing share buybacks.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}